Advancing Innovation in Alternative Pain and Addiction Therapies Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 16, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 16, 2018
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Advancing Innovation in Alternative Pain and Addiction Therapies Act
This bill requires the Food and Drug Administration to issue guidance clarifying eligibility and criteria for the accelerated approval of non-opioid or nonaddictive drugs to treat pain or substance-use disorders.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
3
Cite this page
U.S. Congress. (2026). S. 2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2669/
"S. 2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2669/.
S. 2669, 115th Cong. (2026), https://openamerica.io/bill/115-S-2669/.
[S. 2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act](https://openamerica.io/bill/115-S-2669/)